Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by J Rejas
Pmu55 - Consequences on Economic Outcomes of Generic Versus Brand-Name Drugs Used in Routine Clinical Practice: The Case of Treating Peripheral Neuropathic Pain or Generalized Anxiety Disorder With Pregabalin
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Related publications
Psy92 - Economic and Patient Outcomes of Generic and Brand-Name Statins Used in Routine Clinical Practice in Spain
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
A Cost-Consequences Analysis of the Effect of Pregabalin in the Treatment of Peripheral Neuropathic Pain in Routine Medical Practice in Primary Care Settings
BMC Neurology
Medicine
Neurology
The Concept Of: Generic Drugs and Patented Drugs vs. Brand Name Drugs and Non-Proprietary (Generic) Name Drugs
Frontiers in Pharmacology
Pharmacology
Brand-Name Versus Generic: The Authors Respond
Health Affairs
Medicine
Health Policy
Pharmacotherapy Update: Pregabalin in the Treatment of Generalized Anxiety Disorder
Clinical Medicine Insights: Therapeutics
Medicine
Pharmacology
Pharmaceutical Science
Brand Name or Generic Drugs: A National Survey of Patient Perception and Preferences
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Treatment Persistence and Adherence and Their Consequences on Patient Outcomes of Generic Versus Brand-Name Statins Routinely Used to Treat High Cholesterol Levels in Spain: A Retrospective Cost-Consequences Analysis
Lipids in Health and Disease
Biochemistry
Endocrinology
Clinical Biochemistry
Metabolism
Diabetes
Pregabalin: Dose-Response Relationship in Generalized Anxiety Disorder
Pharmacopsychiatry
Medicine
Psychiatry
Mental Health
Pharmacology
Meta-Analysis of Duloxetine vs. Pregabalin and Gabapentin in the Treatment of Diabetic Peripheral Neuropathic Pain
BMC Neurology
Medicine
Neurology
